Unique ID issued by UMIN | UMIN000027249 |
---|---|
Receipt number | R000031214 |
Scientific Title | Development of an inhalation instruction support system for inhalation therapy |
Date of disclosure of the study information | 2017/05/08 |
Last modified on | 2018/05/31 19:28:31 |
Development of an inhalation instruction support system for inhalation therapy
Development of an inhalation instruction support system
Development of an inhalation instruction support system for inhalation therapy
Development of an inhalation instruction support system
Japan |
Bronchial asthma
Chronic obstructive pulmonary disease(COPD)
Pneumology |
Others
NO
We find that inhalation instruction using a tablet terminal reduces the burden on medical staff or acquires inhalation techniques in a patient.
Efficacy
Time required for medication instruction(first time, 1 month, 2 months, 3 months later).
1) Peak flow rate
2) Pulmonary function test
3) Asthma control test(ACT)
4) COPD assessment test(CAT)
5) Evaluation of inhalation techniques
(first time, 1 month, 2 months, 3 months later)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
Maneuver |
Use a tablet terminal for medication instruction. The patient will see a video of the inhalation techniques in the waiting time at the pharmacy and do not demonstrate the pharmacist with the first instruction.
The frequency of intervention is once a month and the period is three months per case. The type of inhalation medicine and the dosage regimen will be in accordance with what was decided by usual clinical practice.
Do not use tablet terminals for medication instruction. The patient does nothing at the waiting time at the pharmacy, and he does the same medication instruction as before (the pharmacist performs a demonstration).
The frequency of intervention is once a month and the period is three months per case. The type of inhalation medicine and the dosage regimen will be in accordance with what was decided by usual clinical practice.
Not applicable |
Not applicable |
Male and Female
1) Patients diagnosed with bronchial asthma or COPD.
2) Patients prescribed new or modified inhalation medications.
3) Outpatient
4) Patients unnecessary to change pharmacies when receiving prescription medication.
1) Patients who can not use tablets.
2) Patients judged inappropriate for judgment by doctor's judgment.
36
1st name | |
Middle name | |
Last name | Kunio Dobasi |
Gunma University Graduate School
Health Sciences
3-39-22 Showa-machi, Maebashi, Gunma, 371-8511 Japan
027-220-8132
dobashik@gunma-u.ac.jp
1st name | |
Middle name | |
Last name | Kunio Dobashi |
Gunma University Hospital
Department of Respiratory and Allergy
3-39-15 Showa-machi, Maebashi, Gunma, 371-8511 Japan
027-220-8132
dobashik@gunma-u.ac.jp
Gunma Society of Inhalation Therapy
None
Self funding
NO
群馬大学医学部附属病院(群馬県)
2017 | Year | 05 | Month | 08 | Day |
Unpublished
Open public recruiting
2017 | Year | 05 | Month | 05 | Day |
2017 | Year | 05 | Month | 08 | Day |
2019 | Year | 03 | Month | 31 | Day |
2017 | Year | 05 | Month | 05 | Day |
2018 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031214